| Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Science 370 (6522), 1339-1343, 2020 | 902 | 2020 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers CF Houlihan, N Vora, T Byrne, D Lewer, G Kelly, J Heaney, S Gandhi, ... The Lancet 396 (10246), e6-e7, 2020 | 295* | 2020 |
| cGAS–STING and cancer: dichotomous roles in tumor immunity and development KW Ng, EA Marshall, JC Bell, WL Lam Trends in immunology 39 (1), 44-54, 2018 | 204 | 2018 |
| Piwi-interacting RNAs in cancer: emerging functions and clinical utility KW Ng, C Anderson, EA Marshall, BC Minatel, KSS Enfield, HL Saprunoff, ... Molecular cancer 15, 1-13, 2016 | 202 | 2016 |
| Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis EA Marshall, KW Ng, SHY Kung, EM Conway, VD Martinez, EC Halvorsen, ... Molecular cancer 15, 1-15, 2016 | 191 | 2016 |
| SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity A Rosa, VE Pye, C Graham, L Muir, J Seow, KW Ng, NJ Cook, ... SciAdv 7 (22), eabg7607, 2021 | 115 | 2021 |
| Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option KW Ng, J Attig, W Bolland, GR Young, J Major, AG Wrobel, S Gamblin, ... Nature genetics 52 (12), 1294-1302, 2020 | 93 | 2020 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 81 | 2023 |
| SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies KW Ng, N Faulkner, K Finsterbusch, M Wu, R Harvey, S Hussain, M Greco, ... Science translational medicine 14 (655), eabn3715, 2022 | 73 | 2022 |
| Oncogenomic disruptions in arsenic-induced carcinogenesis AP Sage, BC Minatel, KW Ng, GL Stewart, TJB Dummer, WL Lam, ... Oncotarget 8 (15), 25736, 2017 | 68 | 2017 |
| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 60 | 2021 |
| Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma KSS Enfield, EA Marshall, C Anderson, KW Ng, S Rahmati, Z Xu, M Fuller, ... Nature communications 10 (1), 5438, 2019 | 52 | 2019 |
| Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist KW Ng, J Attig, GR Young, E Ottina, SI Papamichos, I Kotsianidis, ... Elife 8, e50256, 2019 | 52 | 2019 |
| Reduced antibody cross-reactivity following infection with B. 1.1. 7 than with parental SARS-CoV-2 strains N Faulkner, KW Ng, MY Wu, R Harvey, M Margaritis, S Paraskevopoulou, ... Elife 10, e69317, 2021 | 51 | 2021 |
| GREM1 is required to maintain cellular heterogeneity in pancreatic cancer L Lan, T Evan, H Li, A Hussain, EJ Ruiz, M Zaw Thin, RMM Ferreira, H Ps, ... Nature 607 (7917), 163-168, 2022 | 40 | 2022 |
| DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer JR Enterina, KSS Enfield, C Anderson, EA Marshall, KW Ng, WL Lam Expert review of respiratory medicine 11 (9), 749-761, 2017 | 32 | 2017 |
| An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations J Boumelha, S de Carné Trécesson, EK Law, P Romero-Clavijo, ... Cancer research 82 (19), 3435-3448, 2022 | 30 | 2022 |
| Large-scale discovery of previously undetected microRNAs specific to human liver BC Minatel, VD Martinez, KW Ng, AP Sage, T Tokar, EA Marshall, ... Human genomics 12, 1-6, 2018 | 24 | 2018 |
| Assessment of long non-coding RNA expression reveals novel mediators of the lung tumour immune response AP Sage, KW Ng, EA Marshall, GL Stewart, BC Minatel, KSS Enfield, ... Scientific reports 10 (1), 16945, 2020 | 22 | 2020 |
| Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma KW Ng, EA Marshall, KSS Enfield, SD Martin, K Milne, ME Pewarchuk, ... Oncoimmunology 7 (12), e1504728, 2018 | 22 | 2018 |
